Germany elects first-ever transgender members of parliament
Tessa Ganserer and Nyke Slawik from the Greens part have made history in Germany as the first transgender women to win parliamentary seats in the recent national election.
This archive collects solutions-journalism stories and milestones from Germany — covering advances in renewable energy, public health, social policy, science, and more. Each entry highlights real progress reported from or about the country.
Tessa Ganserer and Nyke Slawik from the Greens part have made history in Germany as the first transgender women to win parliamentary seats in the recent national election.
The Compact calls on nations to halt the construction of unabated coal-fired power generation projects by the end of this year. Initial signatories include Sri Lanka, Chile, Denmark, Germany, Montenegro, France, and the U.K.
BioNTech, the German company that developed Pfizer’s covid-19 vaccine, is now testing whether mRNAs can treat cancer in humans. The treatment has already completely shrunk tumors in mice.
A research team from Germany’s Martin Luther University Halle-Wittenberg and Brazil’s University of Pará has developed an alternative cement that drastically cuts emissions from production while meeting normal performance requirements.
In 2015, the World Health Organization declared that glyphosate is “probably carcinogenic to humans.” Bayer now faces tens of thousands of legal claims from U.S. customers.
Germany’s Svevind has announced a colossal green hydrogen project that will place some 45 GW of wind and solar energy generation on the steppes of Kazakhstan to produce around 3 million tonnes of green hydrogen annually.
The announcement was made by the country’s culture minister, Monika Grütters, who said Germany will start the restitution of a “substantial” part of the artifacts held in its museums to Nigeria, starting next year.
Having demonstrated the concept, they will begin production of the trucks in 2022 and provide a “dedicated network of Freightliner dealers to support the end-to-end process of fleet electrification.”
New data suggests the experimental vaccine is safe and stimulates a significant immune response that slows tumor progression. A larger Phase 2 trial is currently being planned.
“We will no longer develop a new combustion engine, but will adapt our existing combustion engines to new emission guidelines.”